Home
About Us
Company Profile
Professional Team
Service Process
Certificates of Honor
Professional Qualifications
Clients Served
Strategic Partnerships
Quality Management
Corporate Culture
Self Declaration
Testing Platform
Service Platform
Testing Platform
Virus Detection
Bacterial Strain Detection
Plasmid Detection
Exosome Detection
Mesenchymal Stem Cells (MSCs)
Human Pluripotent Stem Cell
Chinese Hamster Ovary Cell
293T Cell
Chimeric Antigen Receptor T - cell
Natural Killer Cell
Lentivirus
Replicative Virus
AAV
Quality CRO Platform
Quality CRO process
IND registration consulting
IIT registration services
AABB Accreditation
Analytical Method Development and Validation
Human genetic resources management consulting
CNAS&CMA certification consulting
CNAS
CMA
Solutions
Cell banking services
Construction of Detection Platform
Reagent test kit
News
Company News
Industry News
Regulatory Guidelines
Contact Us
Contact Us
Join Us
中
/
EN
CT
|
RAV
Home
About Company
Company Profile
Professional Team
Service Process
Certificates of Honor
Professional Qualifications
Partners
Strategic Partnerships
Quality Management
Corporate Culture
Self Declaration
Testing Platform
Service Platform
Testing Platform
Mesenchymal Stem Cells (MSCs)
Human Pluripotent Stem Cell
Chinese Hamster Ovary Cell
293T Cell
Chimeric Antigen Receptor T - cell
Natural Killer Cell
Virus Detection
Lentivirus
Replicative Virus
AAV
Bacterial Strain Detection
Plasmid Detection
Exosome Detection
Quality CRO Platform
Quality CRO process
IND registration consulting
IIT registration services
AABB Accreditation
Analytical Method Development and Validation
Human genetic resources management consulting
CNAS&CMA certification consulting
CNAS
CMA
Comprehensive Solutions
Cell banking services
Construction of Detection Platform
Reagent test kit
News Media
News and Information
Regulatory Guidelines
Contact Us
Contact Us
Join Us
Language
中文
EN
Leave a Message
Leave a Message
Service Type*
Home
/
News
/
Industry News
国家药监局药审中心关于发布《自体CAR-T细胞治疗产品药学变更研究的问题与解答》的通告
2023-11-17
Source: 明鉴检测
11月16日,国家药监局药审中心关于发布《自体CAR-T细胞治疗产品药学变更研究的问题与解答》的通告。
附件原文如下:
新闻来源:国家药品监督管理局药品审评中心
1
END
1
明
鉴 检 测
Previous:
FDA 发布两篇关于细胞和基因治疗产品安全性检测的指南草案
Next:
CDE发布关于公开征求《人源干细胞产品非临床研究技术指导原则(征求意见稿)》意见的通知